Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microtransplantation for Relapsed/Refractory Hematologic Malignancies
NCT02433483Phase 2Terminated
- Sponsor
- St. Jude Children's Research Hospital
- Start
- May 2015
- Primary completion
- May 2017
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of HPC-A in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), acute lymphoblastic leukemia (ALL), sponsored by St. Jude Children's Research Hospital. Started May 2015; status: terminated.
02
Drugs
HPC-A
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT02433483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02433483.